Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published Date:

Abstract

Artificial intelligence (AI) is emerging as a technology with the power to transform established industries, and with applications from automated manufacturing to advertising and facial recognition to fully autonomous transportation. Advances in each of these domains have led some to call AI the "fourth" industrial revolution [1]. In healthcare, AI is emerging as both a productive and disruptive force across many disciplines. This is perhaps most evident in Diagnostic Radiology and Pathology, specialties largely built around the processing and complex interpretation of medical images, where the role of AI is increasingly seen as both a boon and a threat. In Radiation Oncology as well, AI seems poised to reshape the specialty in significant ways, though the impact of AI has been relatively limited at present, and may rightly seem more distant to many, given the predominantly interpersonal and complex interventional nature of the specialty. In this overview, we will explore the current state and anticipated future impact of AI on Radiation Oncology, in detail, focusing on key topics from multiple stakeholder perspectives, as well as the role our specialty may play in helping to shape the future of AI within the larger spectrum of medicine.

Authors

  • Reid F Thompson
    Oregon Health and Science University, Portland, Oregon; Veterans Affairs Portland Health Care System, Portland, Oregon. Electronic address: thompsre@ohsu.edu.
  • Gilmer Valdes
    Department of Radiation Oncology, University of California, San Francisco, California.
  • Clifton D Fuller
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Colin M Carpenter
    Siris Medical, Redwood City, United States.
  • Olivier Morin
    Department of Radiation Oncology, University of California, San Francisco, California.
  • Sanjay Aneja
    Yale University, New Haven, Connecticut.
  • William D Lindsay
    Oncora Medical, Philadelphia, Pennsylvania.
  • Hugo J W L Aerts
    Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
  • Barbara Agrimson
    Oregon Health and Science University, Portland, Oregon.
  • Curtiland Deville
    Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Seth A Rosenthal
    Sutter General Hospital, accruals for Radiological Associates of Sacramento, Sacramento, California.
  • James B Yu
    Yale University, New Haven, Connecticut.
  • Charles R Thomas
    Oregon Health and Science University, Portland, Oregon.